Clinerion is a company offering real-world data insights from their global hospital network covering over 36 million patients in almost 20 countries, online and refreshed daily. Senglobal talks with Douglas Drake at Clinerion to know more about the health outcomes in clinical trials.
Interview with Clinerion: Health Outcomes in Clinical Trials
Q1. Can you start by explaining a little bit about Clinerion and What are Clinerion’s ambitions for the future?
Clinerion is a company offering real-world data insights from our global hospital network covering over 36 million patients in almost 20 countries, online and refreshed daily. The Clinerion Patient Network Explorer can be used to query real-time, anonymized EHR data that can be used for study feasibility, as well as to follow patient journey and outcomes. Our network contains significant longitudinal data of between 5 to 7 years, on average. Partner hospitals can use our Patient Finder internally for their own patient care, stratification and outreach for clinical research and trial recruitment.
Our goal is to better enable digital healthcare data, not just for care reimbursement but for actual patient care, and better patient outcomes. Digital data is now at the forefront of better patient engagement, diagnosis and monitoring and Clinerion’s technology enables hospitals, care givers and clinical research partners to use the digital resources already within the hospital better.
Q2. What is real-world data (RWD) solutions and How does it enable Pharma to achieve its goals?
Real World Data is entirely about perspective. What health data is needed to answer your question? RWD now encompasses the entire pharmaceutical process from discovery and development into clinical research and commercialization. The specific question requires a specific answer and thereby a specific data capability to answer. EHR data, such as Clinerion´s, help in pre-clinical and clinical understanding of patient journey and outcomes and improving outcomes.
Q3. How does Clinerion use RWD to improve clinical trials and thus health outcomes?
Clinerion is unique in our relationship with our hospitals within our network in that we provide at no charge, a first-ever interface for many member hospitals to see and use their own health information system (HIS) data for their own patient care and stratification. Often this data is used for care reimbursement and not able to be queried by physicians and care givers. However, as part of the digital ecosystem within the hospital, making this data available for actual healthcare is part of Clinerion´s mission of “SMART hospital” enablement and democratization of healthcare data, globally.
Click the download button below to read the complete version of ‘Interview with Clinerion: Health Outcomes in Clinical Trials’ by Senglobal talks with Douglas Drake at Clinerion